⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001854161

Dudley Robert Michael

Reports to the SEC for 1 company · BOSTON, MA

Transactions

11

Companies

1

Filings

9

CIK

0001854161

Forms 4 and 5

Insider transactions

11 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-09-28	RNAZTranscode Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+98K sh	$0.51	+$50K	180,262
2023-06-21	RNAZTranscode Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+12K sh	$2.65	+$31.8K	82,262
2023-06-20	RNAZTranscode Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+6,607 sh	$2.55	+$16.8K	70,262
2023-06-09	RNAZTranscode Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+19K sh	$2.76	+$52.4K	61,155
2023-06-09	RNAZTranscode Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+19K sh	$2.76	+$52.4K	912,114
2023-05-19	RNAZTranscode Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+735K sh	—	—	735,000
2022-12-12	RNAZTranscode Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+135K sh	—	—	135,000
2022-09-14	RNAZTranscode Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+20K sh	$1.15	+$23K	893,114
2022-05-31	RNAZTranscode Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,000 sh	$1.87	+$3,739.8	873,114
2022-05-27	RNAZTranscode Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+28K sh	$1.84	+$51.6K	871,114
2022-02-01	RNAZTranscode Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+135K sh	—	—	135,000

Recent filings

9

Accepted (ET)
Oct 24
Dudley Robert Michael0001104659-23-105924
SEC(opens sec.gov)
Jun 224
Dudley Robert Michael0001104659-23-073872
SEC(opens sec.gov)
Jun 144/A
Dudley Robert Michael0001104659-23-071204
SEC(opens sec.gov)
Jun 134
Dudley Robert Michael0001104659-23-070804
SEC(opens sec.gov)
May 194
Dudley Robert Michael0001104659-23-062813
SEC(opens sec.gov)
Dec 144
Dudley Robert Michael0001104659-22-127084
SEC(opens sec.gov)
Sep 164
Dudley Robert Michael0001104659-22-100931
SEC(opens sec.gov)
Jun 14
Dudley Robert Michael0001104659-22-067099
SEC(opens sec.gov)
Feb 34
Dudley Robert Michael0001104659-22-011081
SEC(opens sec.gov)

Companies

1

Transcode Therapeutics, Inc.Director, Chief Executive OfficerRNAZ

Address

C/O TRANSCODE THERAPEUTICS, INC. 6 LIBERTY SQUARE, #2382

BOSTON, MA, 02109